Isodiol International Inc.
Isodiol International Inc. ("Isodiol") is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
Isodiol International Inc. (ISOL)
Le 23 juillet/July 2018
Isodiol International Inc. has announced a consolidation of its issued and outstanding share capital on the basis of 1 post-consolidation share for each 10 pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 39,580,349.
The shares will begin trading on a consolidated basis and with a new CUSIP number on July 24, 2018.
The name and symbol will not change.